This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
EAU 2019
EAU 2019
Prostate Cancer
Bladder Cancer
Kidney Cancer
UTUC
Endourology
Testicular and Penile Cancer
EAU 2019 Prostate Cancer
Viewing 21-40 of 79 articles
EAU 2019: Testosterone Replacement Therapy Improves Potency Recovery Following Robot-Assisted Radical Prostatectomy
EAU 2019: Conclusions from Recent Oncology Meetings Regarding: Hormone Naïve Prostate Cancer
EAU 2019: Variation in Positive Surgical Margin Status Following Radical Prostatectomy for pT2 Prostate Cancer
EAU 2019: Challenging Paradigms in Advanced Prostate Cancer: A New Era
EAU 2019: 18-year Prostate Cancer-Specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer
EAU 2019: Long-term Oncologic Outcomes of Patients Treated with Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer
EAU 2019: Testosterone Replacement Therapy Prevents Disease Progression in Men Undergoing Radical Prostatectomy
EAU 2019: What is Behind the Microbiota?
EAU 2019: PROpel: Olaparib Combined with Abiraterone as First-Line Therapy In mCRPC
EAU 2019: Theranostics: The Future of Functional Imaging
EAU 2019: Fusion Biopsy Devices: A True Improvement, or Only Marketing?
EAU 2019: Case Based Debate: Hypogonadal Prostate Cancer Patient Following Treatment with Curative Intent: Pro versus Con
EAU 2019: Does Cancer Grade Impact MRI Accuracy in Estimating Lesion Size for Prostate Focal Therapy?
EAU 2019: Evaluating the Predictive Role of Automated Bone Scan Index in Selecting Newly Diagnosed Metastatic Prostate Cancer Patients for Prostate Radiotherapy: A STAMPEDE Trial Exploratory Analysis
EAU 2019: Conclusions from Recent Oncology Meetings Regarding: Castration-Resistant Prostate Cancer
EAU 2018: AUA Lecture: Patient-Reported Outcomes After Prostate Cancer Therapy: How Good Are We Doing?
EAU 2019: Neglected Sexual Side Effects of Radical Prostatectomy and Pelvic Radiotherapy
EAU 2019: Development of Novel Criteria for Active Surveillance Based on Multiparametric MRI Alone in Men with Gleason 3+4 Prostate Cancer
EAU 2019: Natural History of Prostate Cancer on Active Surveillance: Stratification by MRI Using the PRECISE Recommendations
EAU 2019: Young Men with Low Risk Prostate Cancer, A Safe Candidate for Active Surveillance Regardless of the Extent of Biopsy Involvement?
1
2
3
4
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free